128 related articles for article (PubMed ID: 23617541)
1. Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer.
Tao S; Seiler CM; Ronellenfitsch U; Brenner H
Acta Oncol; 2013 Nov; 52(8):1667-75. PubMed ID: 23617541
[TBL] [Abstract][Full Text] [Related]
2. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
3. Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screening.
Tao S; Brenner H
Eur J Cancer Prev; 2013 Jul; 22(4):305-10. PubMed ID: 23702679
[TBL] [Abstract][Full Text] [Related]
4. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers.
Terhaar sive Droste JS; Oort FA; van der Hulst RW; van Heukelem HA; Loffeld RJ; van Turenhout ST; Ben Larbi I; Kanis SL; Neerincx M; Räkers M; Coupé VM; Bouman AA; Meijer GA; Mulder CJ
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):272-80. PubMed ID: 21135261
[TBL] [Abstract][Full Text] [Related]
5. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
[TBL] [Abstract][Full Text] [Related]
6. Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis.
Niedermaier T; Balavarca Y; Brenner H
Am J Gastroenterol; 2020 Jan; 115(1):56-69. PubMed ID: 31850933
[TBL] [Abstract][Full Text] [Related]
7. Predictive power of quantitative and qualitative fecal immunochemical tests for hemoglobin in population screening for colorectal neoplasm.
Huang Y; Li Q; Ge W; Cai S; Zhang S; Zheng S
Eur J Cancer Prev; 2014 Jan; 23(1):27-34. PubMed ID: 23942476
[TBL] [Abstract][Full Text] [Related]
8. Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
van Turenhout ST; Oort FA; van der Hulst RW; Visscher AP; Terhaar sive Droste JS; Scholten P; Bouman AA; Meijer GA; Mulder CJ; van Rossum LG; Coupé VM
BMC Gastroenterol; 2014 Dec; 14():217. PubMed ID: 25528043
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
10. Performance improvements of stool-based screening tests.
van Dam L; Kuipers EJ; van Leerdam ME
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):479-92. PubMed ID: 20833351
[TBL] [Abstract][Full Text] [Related]
11. Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages.
Beaulieu JF; Herring E; Kanaoka S; Tremblay É
Oncotarget; 2016 Mar; 7(12):14684-92. PubMed ID: 26895101
[TBL] [Abstract][Full Text] [Related]
12. Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.
Gies A; Cuk K; Schrotz-King P; Brenner H
Gastroenterology; 2018 Jan; 154(1):93-104. PubMed ID: 28958859
[TBL] [Abstract][Full Text] [Related]
13. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting.
Werner S; Krause F; Rolny V; Strobl M; Morgenstern D; Datz C; Chen H; Brenner H
Clin Cancer Res; 2016 Apr; 22(7):1725-33. PubMed ID: 26561557
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
17. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
18. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
Haug U; Hundt S; Brenner H
Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
[TBL] [Abstract][Full Text] [Related]
19. Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study.
Oort FA; van Turenhout ST; Coupé VM; van der Hulst RW; Wesdorp EI; Terhaar sive Droste JS; Larbi IB; Kanis SL; van Hengel E; Bouman AA; Meijer GA; Mulder CJ
BMC Cancer; 2011 Oct; 11():434. PubMed ID: 21985604
[TBL] [Abstract][Full Text] [Related]
20. Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests.
van Rossum LG; van Rijn AF; van Munster IP; Jansen JB; Fockens P; Laheij RJ; Dekker E
Neth J Med; 2009 May; 67(5):182-6. PubMed ID: 19581668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
